Literature DB >> 12676462

Current status of developmental neurotoxicity: regulatory view.

U Hass1.   

Abstract

The need for developmental neurotoxicity testing has been recognized for decades and guidelines are available, as the USEPA guideline and the OECD draft TG 426. Regulatory testing of industrial chemicals for developmental neurotoxicity is required to some extent, especially for pesticides in the US. Until recently, however, developmental neurotoxicity testing of industrial chemicals has not been a clear regulatory requirement in EU, probably due to the lack of an accepted OECD TG. The revised EU Technical Guidance Document for Risk Assessment (EU-TGD) has now included the OECD draft TG 426 in the testing strategy for new and existing substances, and biocides. Hopefully, this will lead to an improved database for risk assessment of potential developmental neurotoxicants. However, the regulatory authorities and toxicologists will also be faced with the challenge that decisions have to be made concerning e.g. when testing should be requested, how testing should be performed, as well as evaluation of the results and the regulatory consequences. In this paper, these three issues will be discussed based on the recommendations given in the EU-TGD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676462     DOI: 10.1016/s0378-4274(02)00499-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  1 in total

1.  Continuing education course #3: current practices and future trends in neuropathology assessment for developmental neurotoxicity testing.

Authors:  Brad Bolon; Robert H Garman; Hans Jørgen G Gundersen; G Allan Johnson; Wolfgang Kaufmann; Georg Krinke; Peter B Little; Susan L Makris; R Daniel Mellon; Kathleen K Sulik; Karl Jensen
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.